文献速递免疫规划卫生政策与健康促进

2019-2022年全国免疫调查中6月龄至17岁儿童家长疫苗犹豫的变化

Changes in vaccine hesitancy among parents of children aged 6 months - 17 Years, National Immunization Surveys, 2019-2022.
PubMed 文献 · Vaccine · 2024-05-27

分析2019-2022年全国免疫调查数据,评估家长对6月龄至17岁儿童常规疫苗接种的犹豫程度。总体疫苗犹豫率维持在约19.0%,6月龄至4岁儿童家长在COVID-19疫苗授权后疫苗犹豫下降2.2个百分点,5-11岁儿童家长疫苗犹豫上升1.2个百分点。

要点

  • 2019年至2022年,约五分之一的儿童家长报告疫苗犹豫。
  • 6月龄至4岁儿童COVID-19疫苗授权后,调整后疫苗犹豫率从21.6%降至19.4%。
  • 5-11岁儿童COVID-19疫苗授权后,疫苗犹豫率从19.8%升至21.0%。

核心结论

  • 2019年至2022年约五分之一的儿童家长报告疫苗犹豫。
  • 5-11岁儿童COVID-19疫苗授权后家长疫苗犹豫上升,6月龄至4岁儿童下降。

研究设计与样本

  • 分析2019-2022年全国免疫调查数据,评估家长对6月龄至17岁儿童常规疫苗接种的疫苗犹豫。
  • 采用Joinpoint回归分析2019-2022年全国总体及社会人口学亚组的疫苗犹豫趋势。
  • 使用逻辑回归计算COVID-19疫苗授权前后疫苗犹豫患病率差异,报告未调整和调整估计值。

主要发现

  • 2019年第二季度至2022年第三季度,总体疫苗犹豫率维持在约19.0%。
  • 非西班牙裔黑人儿童家长疫苗犹豫平均季度下降幅度最大(β=-0.55;趋势检验p<0.05)。
  • 6月龄至4岁儿童COVID-19疫苗授权后,调整后疫苗犹豫率从21.6%降至19.4%,下降2.2个百分点(95%CI:-3.9,-0.6)。
  • 5-11岁儿童COVID-19疫苗授权后,疫苗犹豫率从19.8%升至21.0%,上升1.2个百分点(95%CI:0.2,2.3)。
  • 非西班牙裔黑人儿童家长疫苗犹豫在12-17岁青少年COVID-19疫苗授权后下降,但在所有年龄组授权前后均显著高于非西班牙裔白人儿童家长。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vaccine hesitancy (VH) has been a major contributor to large outbreaks of vaccine-preventable diseases globally, including in the United States. METHODS: Data from the 2019-2022 National Immunization Surveys were analyzed to assess parental hesitancy toward routine vaccination of their children aged 6 months -17 years. Joinpoint regression was employed to investigate trends in VH from 2019 to 2022 nationally overall and among socio-demographic subgroups. Using logistic regression, the difference between the prevalence of VH before and after the authorization of the COVID-19 vaccine for children aged 6 months-4 years, 5-11 years, and 12-17 years was computed. Both unadjusted and adjusted estimates were reported. VH was also compared within each socio-demographic subgroup with a reference level, at two-time points- before and after the authorization of the COVID-19 vaccine for each age group. RESULTS: Overall, VH remained around 19.0 % from Q2 2019 to Q3 2022. Parents of non-Hispanic Black children had the largest average quarterly decrease in VH (β = -0.55; p < 0.05 by test for trend). After the authorization of the COVID-19 vaccine for children aged 6 months to 4 years, the adjusted percentage of children having parents that reported VH decreased by 2.2 (95 % CI: -3.9, -0.6) percentage points (pp) from 21.6 % to 19.4 %. Conversely, for children aged 5-11 years, VH increased by 1.2 (95 % CI: 0.2, 2.3) pp, from 19.8 % to 21.0 %. VH among parents of non-Hispanic Black children decreased after the authorization of the COVID-19 vaccine for adolescents aged 12-17 years but remained significantly higher compared to parents of non-Hispanic White children before and after authorization of the COVID-19 vaccine for all age groups. DISCUSSION: About 1 in 5 children had parents reporting VH from 2019 to 2022. Parental VH increased after the authorization of the COVID-19 vaccine for children aged 5-11 years and declined for children aged 6 months-4 years.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Vashist K, Yankey D, Elam-Evans LD, et al. Changes in vaccine hesitancy among parents of children aged 6 months - 17 Years, National Immunization Surveys, 2019-2022. Vaccine. 2024. PMID: 38806351. doi:10.1016/j.vaccine.2024.05.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。